BOCA RATON, Fla.--(BUSINESS WIRE)--July 12, 2005--
Leader in Rehabilitation Medicine Expands Traditional Stroke & TBI Therapies to Improve Visual Deficits Once Considered Untreatable
NovaVision, Inc. today announced the NYU Medical Center Rusk Institute of Rehabilitation Medicine (New York, New York) is the latest medical institution to offer patients NovaVision VRT(TM) Vision Restoration Therapy(TM) (VRT). VRT is an FDA-cleared, non-invasive medical device that can help restore vision lost as a result of stroke or traumatic brain injury (TBI), a condition previously considered untreatable. While speech, physical and occupational therapies are the long-standing treatment regimens for stroke and brain trauma patients, VRT is the first FDA-cleared clinical application of rehabilitation for vision loss.
